Clinical Trials Browser

Alzheimer Disease, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Asthma, Cardiovascular Diseases, Ischemic Attack, Transient, Colitis, Ulcerative, Crohn Disease, Dementia, Depression, Diabetes Mellitus, Diverticulum, Gastroesophageal Reflux, Heart Failure, Hepatitis, Chronic, Hyperlipidemias, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Thyroid Diseases, Ulcer, Stroke, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic, Irritable Bowel Syndrome, Musculoskeletal Pain

NCT05613699 2022-11-14

YOUEX

Phase NA Completed

106 enrolled

Alzheimer Disease, Fatigue, Motor Activity, Neoplasms

NCT02789800 2022-11-03

PACEinMM-QC

Phase NA Completed

284 enrolled

GastrointestinalGenitourinaryHead & Neck

Alzheimer Disease, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Asthma, Cardiovascular Diseases, Ischemic Attack, Transient, Colitis, Ulcerative, Crohn Disease, Dementia, Depression, Diabetes Mellitus, Diverticulum, Gastroesophageal Reflux, Heart Failure, Hepatitis, Chronic, Hyperlipidemias, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Thyroid Diseases, Ulcer, Stroke, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic, Irritable Bowel Syndrome, Musculoskeletal Pain

NCT03236792 2022-09-29

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Phase 1/2 Completed

28 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT05407272 2022-06-08

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care

Phase NA Completed

60 enrolled

Genitourinary

Alzheimer Disease, Fibrosis, Heart Failure, Kidney Failure, Chronic, Stroke, Pulmonary Disease, Chronic Obstructive, Acute Kidney Injury

NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Phase 2 Completed

35 enrolled 9 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

NCT03384043 2020-07-08

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

Phase NA Completed

52 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT02986152 2019-11-26

Cancer Distress Coach Mobile App Trial

Phase NA Completed

569 enrolled

Alzheimer Disease, Anxiety Disorders, Depression, Neoplasms, Stress Disorders, Post-Traumatic

NCT02902822 2019-05-17

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Phase NA Completed

461 enrolled

Dermatologic

Alzheimer Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Erysipelas, Herpes Zoster, Impetigo, Melanoma, Molluscum Contagiosum, Nevus, Tinea, Warts, Keratosis, Actinic

NCT02767609 2019-04-30

Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging

Phase NA Completed

1 enrolled 4 charts

Brain Injuries, Traumatic, Alzheimer Disease, Multiple Sclerosis, Neoplasms

NCT02632786 2019-04-05

PRONTO

Phase 2 Completed

129 enrolled 18 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

NCT00348140 2017-09-05

REFLECT-3

Phase 3 Completed

1,468 enrolled 38 charts

Lymphoid

Alzheimer Disease, Lymphoma, Follicular

NCT02859207 2017-06-08

A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Phase 1 Completed

32 enrolled

Lymphoid

Alzheimer Disease, Lymphoma, Follicular

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Phase 3 Completed

862 enrolled 36 charts

Lymphoid

Alzheimer Disease, Lymphoma, Follicular

NCT02108769 2014-04-09

Yogic Breathing Changes Salivary Components

Phase NA Completed

20 enrolled

Alzheimer Disease, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Neurodegenerative Diseases

NCT00411580 2013-03-29

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Phase 1 Completed

58 enrolled

Lymphoid

Alzheimer Disease, Lymphoma, Follicular

Clinical Trials

AMYLOCARP

LETSGO

EVANTHEA

Evaluation of a Self-compassion App in People With Cancer: Feasibility, Acceptability and Changes in Well-being

DECAD

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

SmartPrompt

VKI

S-DeciDeD

PACEinMM-ON

YOUEX

PACEinMM-QC

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

Cancer Distress Coach Mobile App Trial

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging

PRONTO

REFLECT-3

A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Yogic Breathing Changes Salivary Components

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)